Professor Sue Pownall Neuromuscular electrical stimulation, evidence base and practical application Professor Sue Pownall - ppt download

June 05,2024

Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults NICE: Interventional procedures guidance [IPG634] Published date: December 2018 TNMES involves electrically stimulating nerves in the throat or neck, while the person swallows. The aim of NMES is to increase the effectiveness of swallowing therapy by strengthening the muscles involved in swallowing. It also promotes recovery of cortical control of swallowing..
Neuromuscular electrical stimulation, evidence base and practical application. Professor Sue Pownall..
Ampcare s ESP™ (Effective Swallowing Protocol) TENS. All have different parameters..
Transcutaneous neuromuscular electrical stimulation (NMES) is usually used as well as traditional swallowing therapy. Small electrical currents stimulate the peripheral nerve supply of the pharyngeal or laryngeal muscles. Stimulus intensity may be at a low sensory level, or at a higher motor level to trigger muscle contractions. Patient exercises their swallowing muscles while having concurrent electrical stimulation. Treatment duration recommendations vary by device, but can be up to 1 hour. Electrical stimulation can produce feelings ranging from tingling and warmth, to a grabbing sensation..
Rapid review of the published literature on efficacy and safety of this procedure. Comprised a comprehensive literature search and detailed review of the evidence from 11 sources. The evidence included 1 systematic review and meta-analysis, 7 randomised controlled trials, 1 comparative study and 2 case series..
Systematic review and meta-analysis of 12 studies, including 578 patients with stroke or traumatic brain injury, Neuromuscular electrical stimulation (NMES, n=344) or traditional dysphagia therapy (TDT, n=234) Reported a statistically significant overall pooled standardised mean difference of 1.14 (95% confidence interval [CI] to 1.338, p<0.001) in favour of NMES for the improvement in subjective swallowing function. Heterogeneity between the 10 selected studies was statistically significant, indicating inconsistency among the results (I2= 81%, 95% CI: 66% to 89%, p<0.0001). Ding R, Ma F (2016) Effectiveness of Neuromuscular Electrical Stimulation on Dysphagia Treatment in Patients with Neurological Impairments– A Systematic Review and Meta-Analysis. Ann Otolaryngol Rhinol 3(12):.
RCT of 60 patients with post-stroke dysphagia. Treated by NMES with swallowing training (n=30) or swallowing training alone (n=30), Dysphagia scores (range 0 to 10 with lower scores indicating severe dysphagia) improved statistically significantly in both groups (3.92±1.04 before treatment to 8.01±1.20 at 10 days, p<0.01 for the NMES group and 3.83±1.18 to 5.31±1.10, p<0.05 for the control group). The improvement was statistically significantly better in the NMES group than in the control group (p<0.01). Jing Q, Yang X, and Reng Q (2016) Effect of neuromuscular electrical stimulation in patients with post-stroke dysphagia. Medical Science Technology 57(pp 1-5).
RCT of 132 patients with brain injury and dysphagia. Electrical stimulation therapy (EST) applied on the suprahyoid muscle (SM, n=66) or on the suprahyoid and infrahyoid muscles (SI, n=66), Statistically significant before-after improvements in functional dysphagia scale (FDS) scores observed within both groups from 41.2 ± 20.9 to 34.5 ± 20.3 in the EST-SM group and from 44.3 ± 19.1 to 35.7 ± 20.5 in the EST-SI group (p<0.001) Intention-to-treat analysis were not statistically significantly different between groups. Beom J, Oh B M, Choi K H et al. (2015) Effect of Electrical Stimulation of the Suprahyoid Muscles in Brain-Injured Patients with Dysphagia. Dysphagia 30(4),.
Retrospective comparative study of 95 patients with head and neck cancer. Compared patients treated with at least 10 sessions of NMES (n=41) with those who had received fewer than 10 sessions of NMES (n=54), Mean FOIS score decreased in both groups, indicating worsening function. The decrease was statistically significantly less in the NMES group (from at baseline to at mean 4.5 months) compared with the control group (from to 4.593), p< Mean swallowing performance status scale score worsened in both groups 4.5 months after treatment (from to in the NMES group and from to in the control group). Bhatt A D, Goodwin N, Cash E et al. (2015) Impact of transcutaneous neuromuscular..
The systematic review and meta-analysis of 12 studies reported a statistically significant overall pooled standardised mean difference of (95% CI to , p<0.001) in favour of NMES for the reduction of penetration/aspiration. The heterogeneity between the 6 selected studies was statistically significant (I2= 90%, 95% CI: 81% to 95%, p<0.0001). Ding R, Ma F (2016) Effectiveness of Neuromuscular Electrical Stimulation on. Dysphagia Treatment in Patients with Neurological Impairments– A Systematic Review and Meta-Analysis. Ann Otolaryngol Rhinol 3(12):.
RCT of 170 patients with head and neck cancer. NMES combined with swallow exercise (n=116) or sham NMES combined with swallow exercise (n=54) Mean penetration-aspiration scale (PAS) scores for NMES remained unchanged after 13-week treatment (PAS scores of 5.13 at baseline and 5.14 at 13 weeks) and the mean PAS scores for sham NMES improved from 5.48 at baseline to 4.91 at 13 weeks. Adjusting for differences in baseline, this resulted in a difference of 0.52 on PAS (95% CI 0.06 to 0.98, p=0.027) indicating statistically significantly greater improvement in the sham NMES group. Langmore S E, McCulloch T M, Krisciunas G P et al. (2016) Efficacy of electrical stimulation and exercise for dysphagia in patients with head and neck cancer: A randomized clinical trial. Head and Neck 38 (pp E1221-E1231)..
The systematic review and meta-analysis of 12 studies reported a statistically significant overall pooled standardised mean difference of (95% CI to , p<0.001) in favour of NMES for the reduction of pharyngeal transit time. The heterogeneity between the 4 selected studies was statistically significant (I2= 77%, 95% CI: 39% to 92%, p=0.004). Ding R, Ma F (2016) Effectiveness of Neuromuscular Electrical Stimulation on. Dysphagia Treatment in Patients with Neurological Impairments– A Systematic Review. and Meta-Analysis. Ann Otolaryngol Rhinol 3(12):.
RCT of 108 post-stroke patients with dysphagia. Transcutaneous electrical nerve stimulation (TENS, n=54) with orofacial rehabilitation (OFR) or OFR only (n=54) Statistically significant difference for the change in oral transit time after 4 weeks of therapy between the group who had TENS (mean 0.55 seconds ± 0.01) and the control group (mean 0.29 seconds± 0.03) (p=0.01). Difference was also statistically significant between groups for the change in pharyngeal transit time after 4 weeks of therapy: mean 0.37 seconds ± 0.02 for the TENS group and mean 0.15 seconds ± 0.02 for the control group (p=0.009). Konecny P, and Elfmark M (2017) Electrical stimulation of hyoid muscles. in post-stroke dysphagia. Biomed Pap Med Fac Univ Palacky. Olomouc Czech Repub..
Head and neck cancer inventory (HNCI) scores were not statistically significantly different between the group who had NMES and the group who had sham NMES after 13 weeks of treatment. Performance status scale (PSS) scores were also not statistically significantly different between the group who had NMES and the group who had sham NMES after 13 weeks of treatment. Langmore S E, McCulloch T M, Krisciunas G P et al. (2016) Efficacy of electrical stimulation and exercise for dysphagia in patients with head and neck cancer: A randomized clinical trial. Head and Neck 38 (pp E1221-E1231)..
Mean SWAL-QoL scores increased from 107 at baseline to 128 after 1 month post-treatment in the NMES group and from 118 to 121 in the control group (with a statistically significant difference between groups adjusted for baseline [95% CI]: 20.5 [4.2–36.7]). One month post treatment, both groups showed continued improvement, with 100% (12/12) of patients in the NMES group reporting improved SWAL-QoL scores compared with 42% (5/12) of patients in the control group. Sproson L, Pownall S, Enderby P et al. (2018) Combined electrical stimulation and exercise for swallow rehabilitation post-stroke: a pilot randomized control trial. International Journal of Language and Communication Disorders; 53(2):.
The specialist advisers and committee considered the key efficacy outcomes to be: improvement in swallowing and oral intake, and improved quality of life. The specialist advisers and the committee considered the key safety outcomes to be: skin burn and aspiration. Many comments from patients during consultation. The patients reported positive outcomes after the procedure..
Current evidence on transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults shows there are no major safety concerns. For adults with dysphagia after a stroke, the evidence on efficacy suggests a potential benefit, but is limited in quality and quantity. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. For adults with dysphagia not caused by a stroke, there is insufficient evidence on efficacy to support the use of this procedure. Therefore, this procedure should only be used in the context of research..
Different parameters. Different electrodes. Ampcare ESP™ pie shaped, Vital stim® round. Electrical current disperses differently. Ampcare ESP™ incorporates a Postural Device so targeted exercises are completed against resistance. Latest Vital stim® unit has biofeedback system. Watts 2013 showed a 2-fold increase in hyolaryngeal muscle activation using Ampcare’s Posture Device versus traditional head lift exercises. Watts, C. R. (2013). Measurement of Hyolaryngeal Muscle Activation Using Surface Electromyography for Comparison..
Differences in parameters NMES.
Practical Application Ampcare ESP™.
2 stroke, 2 head and neck cancer, 1 osteomyelitis. 3 patients able to have PEG tubes removed. Quality of life - Participant responses..
Comparing: Usual UK dysphagia care. Ampcare Effective Swallowing Protocol (ESP™) Outcome Measures included: FOIS (functional oral intake scale) Videofluoroscopy – blinded assessment using Rosenbek Penetration Aspiration scale. Tolerability and SWAL-QoL questionnaires..
each weekday. for 20 treatments (approximately 4 weeks).
50% of usual care group improved, compared to 62% of. the intervention group. FOIS: 1 month follow up: 57% of usual care group improved, compared to 75% of the intervention group..
Intervention: 58% improved with fluids & 67% on diet. SWAL-QoL: Usual care: 39% reported improved quality of life by end of. treatment & 42% at 1 month follow up. Intervention: 83% reported improved quality of life by end. of treatment & 100% at 1 month follow up..
Patient feedback: I feel better at swallowing – no problems swallowing at all now. I thought the treatment was very good and I would recommend it to anybody. I’ve enjoyed taking part. It’s given me a positive feeling about my swallow. Carer feedback: He can drive short distances now without having to pull over to use the pot. He sleeps through the night now without waking up coughing. She’s definitely not coughing anywhere near as much now..
the treatment is safe and tolerable. The pilot study findings justified progression to a fully. powered trial. We had piloted the outcome measures successfully. Based on the findings from the pilot results, power. calculations indicated need of around 220 participants. for the full scale study, involving around 12 UK sites. Sproson L, Pownall S, Enderby P et al. (2018) Combined electrical stimulation and exercise for. swallow rehabilitation post-stroke: a pilot randomized control trial. International Journal of Language and. Communication Disorders; 53(2):.
NIHR HTA Application Unsuccessful at second stage.
Documentation for new intervention – Trust governance. 13 SLTs trained. Hospital Charity funding 1 year. Registered as service evaluation using NICE audit standards and documentation. Introduced in routine practice 2018 onwards. 24 patients – 14 stroke, 10 non-stroke. SSNAP 45 mins of therapy a day. Not all had Ampcare ESP 5x a week..
Very promising outcomes. Both stroke and non-stroke. Submitted for publication..
6 patients (5 stroke, 1 non-stroke) nil-by mouth before treatment, safely introduced some oral intake following completion of treatment. 2 patients (both stroke) were able to meet nutrition and hydration needs orally after treatment and were able to avoid long term artificial feeding (PEG feeding) 4 patients (3 stroke and 1 non-stroke) have either had their PEGs removed or awaiting PEG removal due to the improvement in their swallow. 2 of these 4 patients had 2 courses of Ampcare ESP..
2 experienced significant medical deterioration during the course of the therapy, necessitating hospital admissions. Deterioration was unrelated to the Ampcare ESP (for example, urine tract infection) but any medical deterioration in a patient with dysphagia is likely to result in a worsening of symptoms. 2 patients were referred on to neurology as through the regular contact with them during the course of therapy it became clear that there was more to their difficulties than initially thought..
Sample size halved. Fewer sites needed. Demonstrated can be implemented in routine NHS provision. Cost vs benefit Health economics. Continuing to offer to patients as part of routine care..
Professor Pam Enderby. Patients and their families. All our funders..
Sheffield Teaching Hospitals NHS Foundation Trust. Sheffield Hospitals Charity. Ampcare LLC, Texas. NIHR Devices for Dignity HTC, Sheffield. Collaboration for Leadership in Applied Health Research (South Yorkshire) Royal College of Nursing (Lady Foley Award). The views expressed are my own and are not necessarily those of the funders.